DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Thiotepa (Thiotepa Intracavitary) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Death (29)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Thiotepa (Thiotepa Intracavitary) death. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Thiotepa side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-17

Patient:

Reactions: Nephropathy Toxic, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Valaciclovir
    Indication: Antiviral Prophylaxis

Rabbit Antithymocyte Immu (Formulation Unknown) (Rabbit Antithymocyte
    Indication: Haematological Malignancy

Melphalan Hydrochloride
    Dosage: 140 mg/m2/
    Indication: Haematological Malignancy

Fludarabine Phosphate
    Dosage: 160 mg/m2/
    Indication: Haematological Malignancy

Levofloxacin
    Indication: Antibiotic Prophylaxis

Thiotepa
    Dosage: 10 mg/kg/
    Indication: Haematological Malignancy



Possible Thiotepa side effects in male

Reported by a physician from Germany on 2012-04-23

Patient: male, weighing 14.8 kg (32.6 pounds)

Reactions: Peritonitis Bacterial, Sepsis, Neutropenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Fludara
    Indication: Stem Cell Transplant

Treosulfan
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-06
    End date: 2011-09-12

Treosulfan
    Indication: Stem Cell Transplant

Thiotepa
    Indication: Stem Cell Transplant

Anti-Thymocyte Globulin Equine NOS
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-06
    End date: 2011-09-12

Clofarabine
    Dosage: 44 mg/m2, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-08-10
    End date: 2011-08-14

Fludara
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-06
    End date: 2011-09-12

Etopophos Preservative Free
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-08-10
    End date: 2011-08-14

Cyclophosphamide
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-08-10
    End date: 2011-08-14

Thiotepa
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-06
    End date: 2011-09-12

Anti-Thymocyte Globulin Equine NOS
    Indication: Stem Cell Transplant

Other drugs received by patient: Acyclovir; Amikacin; Zyvox; Granocyte; Cyclosporine; Amikacin; Acyclovir; Tigecycline; Zyvox; Prednisolone; Granocyte; Tigecycline



Possible Thiotepa side effects in 3 year old

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-04-17

Patient: 3 year old

Reactions: Respiratory Failure, Pneumomediastinum, Acute Respiratory Distress Syndrome, Pneumothorax

Adverse event resulted in: death

Drug(s) suspected as cause:
Carboplatin
    Dosage: unk
    Indication: Medulloblastoma

Cyclophosphamide
    Dosage: unk
    Indication: Medulloblastoma

Etoposide
    Dosage: unk
    Indication: Medulloblastoma

Thiotepa
    Dosage: unk
    Indication: Medulloblastoma



Possible Thiotepa side effects in 65 year old male

Reported by a physician from United States on 2012-04-17

Patient: 65 year old male

Reactions: Encephalitis Cytomegalovirus, Graft Versus Host Disease, Central Nervous System Lesion, Panencephalitis, CNS Ventriculitis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Thiotepa
    Indication: Diffuse Large B-Cell Lymphoma

Thiotepa
    Indication: Myeloid Leukaemia

Thiotepa
    Indication: Myelodysplastic Syndrome

Rituximab
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Indication: Myeloid Leukaemia

Rituximab
    Indication: Myelodysplastic Syndrome

Idarubicin HCL
    Indication: Diffuse Large B-Cell Lymphoma

Idarubicin HCL
    Indication: Myelodysplastic Syndrome

Idarubicin HCL
    Indication: Myeloid Leukaemia

Fludarabine Phosphate
    Indication: Diffuse Large B-Cell Lymphoma

Fludarabine Phosphate
    Indication: Myelodysplastic Syndrome

Fludarabine Phosphate
    Indication: Myeloid Leukaemia

Etoposide
    Indication: Diffuse Large B-Cell Lymphoma

Etoposide
    Indication: Myelodysplastic Syndrome

Etoposide
    Indication: Myeloid Leukaemia

Valaciclovir
    Indication: Myeloid Leukaemia

Valaciclovir
    Indication: Cytomegalovirus Infection

Valaciclovir
    Indication: Myelodysplastic Syndrome

Depocyt
    Indication: Diffuse Large B-Cell Lymphoma

Depocyt
    Indication: Myelodysplastic Syndrome

Depocyt
    Indication: Myeloid Leukaemia

Mitoxantrone
    Indication: Myelodysplastic Syndrome

Mitoxantrone
    Indication: Myeloid Leukaemia

Mitoxantrone
    Indication: Diffuse Large B-Cell Lymphoma

Anti-Thymocyte Globulin Equine NOS
    Indication: Diffuse Large B-Cell Lymphoma

Anti-Thymocyte Globulin Equine NOS
    Indication: Myelodysplastic Syndrome

Anti-Thymocyte Globulin Equine NOS
    Indication: Myeloid Leukaemia

Foscarnet
    Indication: Myelodysplastic Syndrome

Foscarnet
    Indication: Cytomegalovirus Infection

Foscarnet
    Indication: Myeloid Leukaemia

Acyclovir
    Indication: Myeloid Leukaemia

Acyclovir
    Indication: Cytomegalovirus Infection

Acyclovir
    Indication: Myelodysplastic Syndrome



Possible Thiotepa side effects in 3 year old

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-04-12

Patient: 3 year old

Reactions: Respiratory Failure, Pneumomediastinum, Hypercapnia, Pneumothorax, Acute Respiratory Distress Syndrome, Platelet Count Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Medulloblastoma

Etoposide
    Indication: Medulloblastoma

Carboplatin
    Indication: Medulloblastoma

Thiotepa
    Indication: Medulloblastoma



Possible Thiotepa side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-11

Patient:

Reactions: Stem Cell Transplant, Pulmonary Alveolar Haemorrhage

Adverse event resulted in: death

Drug(s) suspected as cause:
Melphalan Hydrochloride
    Dosage: 140 mg/m2
    Indication: Neuroblastoma

Busulfan
    Dosage: 600 mg/m2
    Indication: Neuroblastoma

Thiotepa
    Dosage: 300 mg/m2 / per day
    Indication: Neuroblastoma



Possible Thiotepa side effects in 3 year old

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-04-10

Patient: 3 year old

Reactions: Respiratory Failure

Adverse event resulted in: death

Drug(s) suspected as cause:
Thiotepa
    Indication: Medulloblastoma

Cyclophosphamide
    Indication: Medulloblastoma

Etoposide
    Indication: Medulloblastoma

Carboplatin
    Indication: Medulloblastoma



Possible Thiotepa side effects in 3 year old

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-04-06

Patient: 3 year old

Reactions: Respiratory Failure

Adverse event resulted in: death

Drug(s) suspected as cause:
Etoposide
    Indication: Medulloblastoma

Carboplatin
    Indication: Medulloblastoma

Thiotepa
    Indication: Medulloblastoma

Cyclophosphamide
    Indication: Medulloblastoma



Possible Thiotepa side effects in 6 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-02

Patient: 6 year old female

Reactions: Pneumonia, Abscess Fungal, Mental Status Changes, Renal Abscess, Pyrexia, Convulsion, Stem Cell Transplant, Encephalitis Cytomegalovirus, Graft Versus Host Disease in Skin, Sepsis, Hydrocephalus, CNS Ventriculitis

Adverse event resulted in: death

Drug(s) suspected as cause:
Methylprednisolone
    Dosage: not reported, unknown, unknown
    Indication: Graft Versus Host Disease

Anti-Thymocyte Globulin Equine NOS
    Dosage: not reported, unknown, unknown
    Indication: Acute Lymphocytic Leukaemia Recurrent

Cytarabine
    Dosage: not reported, unknown, unknown
    Indication: Acute Lymphocytic Leukaemia Recurrent

Therapeutic Radiopharmaceuticals
    Dosage: not reported, unknown, other
    Indication: Acute Lymphocytic Leukaemia Recurrent

Thiotepa
    Dosage: not reported, unknown, unknown
    Indication: Acute Lymphocytic Leukaemia Recurrent

Immune Globulin NOS
    Dosage: not reported, unknown, unknown
    Indication: Acute Lymphocytic Leukaemia Recurrent

Ganciclovir
    Dosage: 12 mg/kg, unknown, unknown
    Indication: Cytomegalovirus Viraemia

Corticosteroids
    Dosage: not reported, unknown, unknown
    Indication: Acute Lymphocytic Leukaemia Recurrent

Cidofovir
    Dosage: two doses, unknown, unknown
    Indication: Cytomegalovirus Viraemia

Foscarnet Sodium
    Dosage: 90 mg/kg, unknown, unknown
    Indication: Cytomegalovirus Viraemia

Monoclonal Antibodies
    Dosage: not reported, unknown, unknown
    Indication: Graft Versus Host Disease



Possible Thiotepa side effects in 65 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-30

Patient: 65 year old male

Reactions: Encephalitis Cytomegalovirus, CNS Ventriculitis

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Dosage: not reported, unknown, unknown
    Indication: Myelodysplastic Syndrome

Cytarabine
    Dosage: not reported, unknown, unknown
    Indication: Diffuse Large B-Cell Lymphoma

Cytarabine
    Dosage: not reported, unknown, unknown
    Indication: Acute Myeloid Leukaemia

Idarubicin HCL
    Dosage: not reported, unknown, unknown
    Indication: Myelodysplastic Syndrome

Idarubicin HCL
    Dosage: not reported, unknown, unknown
    Indication: Diffuse Large B-Cell Lymphoma

Valaciclovir
    Dosage: not reported, unknown, unknown
    Indication: Cytomegalovirus Viraemia

Etoposide
    Dosage: not reported, unknown, unknown
    Indication: Myelodysplastic Syndrome

Etoposide
    Dosage: not reported, unknown, unknown
    Indication: Diffuse Large B-Cell Lymphoma

Acyclovir
    Dosage: not reported, unknown, unknown
    Indication: Cytomegalovirus Viraemia

Rituximab
    Dosage: not reported, unknown, unknown
    Indication: Myelodysplastic Syndrome

Rituximab
    Dosage: not reported, unknown, unknown
    Indication: Diffuse Large B-Cell Lymphoma

Foscarnet Sodium
    Dosage: not reported, unknown, unknown
    Indication: Cytomegalovirus Viraemia

Mitoxantrone Hydrochloride
    Dosage: not reported, unknown, unknown
    Indication: Diffuse Large B-Cell Lymphoma

Mitoxantrone Hydrochloride
    Dosage: not reported, unknown, unknown
    Indication: Myelodysplastic Syndrome

Anti-Thymocyte Globulin Equine NOS
    Dosage: not reported, unknown, unknown
    Indication: Myelodysplastic Syndrome

Anti-Thymocyte Globulin Equine NOS
    Dosage: not reported, unknown, unknown
    Indication: Acute Myeloid Leukaemia

Anti-Thymocyte Globulin Equine NOS
    Dosage: not reported, unknown, unknown
    Indication: Diffuse Large B-Cell Lymphoma

Fludarabine Phosphate
    Dosage: not reported, unknown, unknown
    Indication: Diffuse Large B-Cell Lymphoma

Fludarabine Phosphate
    Dosage: not reported, unknown, unknown
    Indication: Myelodysplastic Syndrome

Fludarabine Phosphate
    Dosage: not reported, unknown, unknown
    Indication: Acute Myeloid Leukaemia

Therapeutic Radiopharmaceuticals
    Dosage: not reported, unknown, other
    Indication: Diffuse Large B-Cell Lymphoma

Therapeutic Radiopharmaceuticals
    Dosage: not reported, unknown, other
    Indication: Myelodysplastic Syndrome

Thiotepa
    Dosage: not reported, unknown, unknown
    Indication: Myelodysplastic Syndrome

Thiotepa
    Dosage: not reported, unknown, unknown
    Indication: Acute Myeloid Leukaemia

Thiotepa
    Dosage: not reported, unknown, unknown
    Indication: Diffuse Large B-Cell Lymphoma



Possible Thiotepa side effects in 3 year old

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-03-29

Patient: 3 year old

Reactions: Respiratory Failure, Pneumomediastinum, Acute Respiratory Distress Syndrome, Pneumothorax

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Etoposide
    Dosage: hit 2000 met-bis4 protocol
    Indication: Medulloblastoma

Thiotepa
    Dosage: hit 2000 met-bis4 protocol
    Indication: Medulloblastoma

Cyclophosphamide
    Dosage: hit 2000 met-bis4 protocol
    Indication: Medulloblastoma

Carboplatin
    Dosage: hit 2000 met-bis4 protocol
    Indication: Medulloblastoma



Possible Thiotepa side effects in 3 year old

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-03-29

Patient: 3 year old

Reactions: Respiratory Failure, Acute Respiratory Distress Syndrome

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: hit 2000 met-bis4 protocol
    Indication: Medulloblastoma

Carboplatin
    Dosage: hit 2000 met-bis4 protocol
    Indication: Medulloblastoma

Etoposide
    Dosage: hit 2000 met-bis4 protocol
    Indication: Medulloblastoma

Thiotepa
    Dosage: hit 2000 met-bis4 protocol
    Indication: Medulloblastoma



Possible Thiotepa side effects in 3 year old

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-03-27

Patient: 3 year old

Reactions: Death, Respiratory Failure, Hypercapnia, Pneumomediastinum, Acute Respiratory Distress Syndrome, Pneumothorax

Adverse event resulted in: death

Drug(s) suspected as cause:
Carboplatin
    Indication: Medulloblastoma

Thiotepa
    Indication: Medulloblastoma

Cyclophosphamide
    Indication: Medulloblastoma

Etoposide
    Indication: Medulloblastoma



Possible Thiotepa side effects in 3 year old

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-03-22

Patient: 3 year old

Reactions: Death, Respiratory Failure, Hypercapnia, Pneumomediastinum, Acute Respiratory Distress Syndrome, Pneumothorax

Adverse event resulted in: death

Drug(s) suspected as cause:
Thiotepa
    Indication: Medulloblastoma

Cyclophosphamide
    Indication: Medulloblastoma

Etoposide
    Indication: Medulloblastoma

Carboplatin
    Indication: Medulloblastoma



Possible Thiotepa side effects in 56 year old male

Reported by a physician from Norway on 2012-02-06

Patient: 56 year old male

Reactions: Cerebral Haemorrhage

Adverse event resulted in: death

Drug(s) suspected as cause:
Carboplatin
    Dosage: 7x(gfr+25) mg daily, cyclic (day1-4)
    Indication: Testis Cancer

Cyclophosphamide
    Dosage: 1500 mg/m2 daily, cyclic (day 1-4)
    Indication: Testis Cancer

Thiotepa
    Dosage: 120 mg/m2 daily, cyclic (day 1-4)
    Indication: Testis Cancer



Possible Thiotepa side effects in male

Reported by a physician from United Kingdom on 2012-02-02

Patient: male

Reactions: Venoocclusive Disease, Cytomegalovirus Infection, Acidosis, Pneumonia Cytomegaloviral

Adverse event resulted in: death

Drug(s) suspected as cause:
Thiotepa
    Indication: Bone Marrow Conditioning Regimen

Cyclosporine
    Indication: Prophylaxis Against Graft Versus Host Disease

Busulfan
    Dosage: 14mgk unknown
    Indication: Bone Marrow Conditioning Regimen

Methotrexate
    Indication: Prophylaxis Against Graft Versus Host Disease

Cyclophosphamide
    Dosage: 200mgk unknown
    Indication: Bone Marrow Conditioning Regimen

Alemtuzumab
    Indication: Bone Marrow Conditioning Regimen



Possible Thiotepa side effects in 65 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-23

Patient: 65 year old male

Reactions: Multi-Organ Failure, Lung Disorder

Adverse event resulted in: death

Drug(s) suspected as cause:
Busulfan
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2011-12-02
    End date: 2011-12-04

Cyclophosphamide
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2011-12-05
    End date: 2011-12-06

Thiotepa
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2011-11-29
    End date: 2011-12-01

Mesna
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-05
    End date: 2011-12-06

Other drugs received by patient: Clonazepam



Possible Thiotepa side effects in 15 month old male

Reported by a physician from Canada on 2011-12-16

Patient: 15 month old male

Reactions: Aspiration, Leukoencephalopathy

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Thiotepa
    Indication: Brain Neoplasm Malignant

Carboplatin
    Indication: Brain Neoplasm Malignant



Possible Thiotepa side effects in 17 year old female

Reported by a physician from United States on 2011-12-12

Patient: 17 year old female

Reactions: Graft Versus Host Disease

Adverse event resulted in: death

Drug(s) suspected as cause:
Fludarabine Phosphate
    Indication: Leukaemia

Melphalan Hydrochloride
    Indication: Leukaemia

Thiotepa
    Indication: Leukaemia

Other drugs received by patient: Anti-Thymocyte Globulin NOS



Possible Thiotepa side effects in 17 year old female

Reported by a physician from United States on 2011-12-12

Patient: 17 year old female

Reactions: Graft Versus Host Disease

Adverse event resulted in: death

Drug(s) suspected as cause:
Fludarabine Phosphate
    Indication: Leukaemia

Thiotepa
    Indication: Leukaemia

Melphalan Hydrochloride
    Indication: Leukaemia

Other drugs received by patient: Immune Globulin NOS; Antithymocyte



Possible Thiotepa side effects in female

Reported by a physician from United States on 2011-12-02

Patient: female, weighing 53.0 kg (116.6 pounds)

Reactions: Thrombosis, Hepatic Function Abnormal, Citrobacter Infection, Hyperbilirubinaemia, Atrial Flutter, Pulmonary Alveolar Haemorrhage, Cerebral Ischaemia, Mucosal Inflammation, Renal Failure, Neoplasm Malignant, Acute Respiratory Distress Syndrome, Acute Respiratory Failure, Hypertension

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Clolar
    Dosage: 20 mg/m2, qdx5
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-11-15
    End date: 2010-11-19

Melphalan Hydrochloride
    Dosage: 110 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-11-21
    End date: 2010-11-22

Thiotepa
    Dosage: 600 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-11-20
    End date: 2010-11-20

Other drugs received by patient: Tacrolimus; Filgrastim; Mycophenolate Mofetil; Methotrexate; Methotrexate; Mycophenolate Mofetil



Possible Thiotepa side effects in 15 month old male

Reported by a individual with unspecified qualification from Canada on 2011-11-25

Patient: 15 month old male

Reactions: Leukoencephalopathy

Adverse event resulted in: death

Drug(s) suspected as cause:
Methotrexate
    Indication: Brain Neoplasm Malignant

Etoposide
    Indication: Brain Neoplasm Malignant

Carboplatin
    Indication: Brain Neoplasm Malignant

Thiotepa
    Indication: Brain Neoplasm Malignant

Cisplatin
    Indication: Brain Neoplasm Malignant

Cyclophosphamide
    Indication: Brain Neoplasm Malignant



Possible Thiotepa side effects in 15 month old male

Reported by a health professional (non-physician/pharmacist) from Canada on 2011-11-24

Patient: 15 month old male

Reactions: Aspiration, Leukoencephalopathy

Adverse event resulted in: death

Drug(s) suspected as cause:
Etoposide

Carboplatin

Cyclophosphamide

Methotrexate
    Dosage: 1df= 8 g/m2

Vincristine
    Dosage: two doses

Thiotepa
    Dosage: 2 doses

Cisplatin



Possible Thiotepa side effects in 15 month old male

Reported by a health professional (non-physician/pharmacist) from Canada on 2011-11-11

Patient: 15 month old male

Reactions: Death, Metastatic Neoplasm, Dysphagia, Central Nervous System Lesion

Adverse event resulted in: death

Drug(s) suspected as cause:
Vincristine
    Dosage: 0.065 mg/kg, unk
    Indication: Chemotherapy

Etoposide
    Dosage: 2.5 mg/kg/day
    Indication: Chemotherapy

Radiotherapy
    Dosage: 50.4 gy, unk

Thiotepa
    Indication: Chemotherapy

Cisplatin
    Dosage: 3.5 mg/kg, unk

Methotrexate
    Dosage: 8 mg/m2, unk
    Indication: Chemotherapy

Carboplatin
    Indication: Chemotherapy

Cyclophosphamide
    Dosage: 0.05 mg/kg/day
    Indication: Chemotherapy



Possible Thiotepa side effects in 18 month old female

Reported by a individual with unspecified qualification from Canada on 2011-11-11

Patient: 18 month old female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Methotrexate
    Dosage: 8 mg/m2, unk
    Indication: Chemotherapy

Cyclophosphamide
    Dosage: 0.05 mg/kg/day
    Indication: Chemotherapy

Vincristine
    Dosage: 0.065 mg/kg, unk
    Indication: Chemotherapy

Thiotepa
    Dosage: 10 mg/kg/day
    Indication: Chemotherapy

Radiotherapy
    Dosage: 50.4 gy, unk

Carboplatin
    Dosage: 17 mg/kg/day
    Indication: Chemotherapy

Cisplatin
    Dosage: 3.5 mg/kg, unk

Etoposide
    Dosage: 2.5 mg/kg/day
    Indication: Chemotherapy



Possible Thiotepa side effects in 15 month old male

Reported by a physician from Canada on 2011-11-10

Patient: 15 month old male

Reactions: Aspiration, Leukoencephalopathy

Adverse event resulted in: death

Drug(s) suspected as cause:
Thiotepa
    Indication: Brain Neoplasm Malignant

Carboplatin
    Indication: Brain Neoplasm Malignant



Possible Thiotepa side effects in male

Reported by a physician from United Kingdom on 2011-10-19

Patient: male, weighing 14.8 kg (32.6 pounds)

Reactions: Peritonitis Bacterial, Sepsis, Neutropenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-08-10
    End date: 2011-08-14

Fludara
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-06
    End date: 2011-09-12

Thiotepa
    Indication: Stem Cell Transplant

Etopophos Preservative Free
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-08-10
    End date: 2011-08-14

Anti-Thymocyte Globulin NOS
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-06
    End date: 2011-09-12

Anti-Thymocyte Globulin NOS
    Indication: Stem Cell Transplant

Clofarabine
    Dosage: 44 mg/m2, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-08-10
    End date: 2011-08-14

Fludara
    Indication: Stem Cell Transplant

Treosulfan
    Indication: Stem Cell Transplant

Thiotepa
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-06
    End date: 2011-09-12

Treosulfan
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-06
    End date: 2011-09-12

Other drugs received by patient: Amikacin; Acyclovir; Zyvox; Granocyte; Tigecycline; Cyclosporine; Amikacin; Prednisolone; Tigecycline; Zyvox; Granocyte; Acyclovir



Possible Thiotepa side effects in male

Reported by a physician from United States on 2011-10-18

Patient: male

Reactions: Acute Leukaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Clolar
    Dosage: unk
    Indication: Acute Leukaemia

Thiotepa
    Indication: Stem Cell Transplant

Melphalan Hydrochloride
    Dosage: 70 mg/m2, qd
    Indication: Acute Leukaemia

Thiotepa
    Dosage: 10 mg/kg, qd
    Indication: Acute Leukaemia

Melphalan Hydrochloride
    Indication: Stem Cell Transplant

Other drugs received by patient: Tacrolimus



Possible Thiotepa side effects in

Reported by a physician from United States on 2011-10-14

Patient:

Reactions: Acute Leukaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Melphalan Hydrochloride
    Dosage: 70 mg/m2, qd
    Indication: Acute Leukaemia

Thiotepa
    Indication: Stem Cell Transplant

Clolar
    Indication: Stem Cell Transplant

Thiotepa
    Dosage: 10 mg/kg, qd
    Indication: Acute Leukaemia

Melphalan Hydrochloride
    Indication: Stem Cell Transplant

Clolar
    Dosage: unk
    Indication: Acute Leukaemia

Other drugs received by patient: Tacrolimus

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017